Medical Bulletin 23/October/2021

Published On 2021-10-23T17:45:50+05:30 | Updated On 23 Oct 2021 12:15 PM GMT

Overview

Here are Top Medical stories of the day

A combination pill approved for severe acute pain in adults

The US Food and Drug Administration (FDA) has approved Seglentis a combination of celecoxib and tramadol hydrochloride for severe acute pain in adults, especially when alternative treatments fail to provide adequate pain relief.

It is an innovative first-in-class product comprised of a co-crystal form of celecoxib an anti-inflammatory drug and tramadol ,an analgesic for the treatment of acute pain in adults.

For more details, check out the full story on the link below:

FDA Approves Combination Pill For Severe Acute Pain In Adults

Regular Millet consumption may improve iron deficiency Anemia, finds study

The prevalence of iron deficiency anemia is highest among low and middle-income countries where Millets, including sorghum, rich in iron are a traditional staple diet. A wide variation in the iron composition of millets has been reported, which needs to be understood in consonance with its bioavailability and roles in reducing anemia.

Regular consumption of millets can improve hemoglobin and serum ferritin levels to reduce iron deficiency anemia, finds a new study.

For more details, check out the full story on the link below:

Regular Millet Consumption May Improve Iron Deficiency Anemia, Finds Study

Novel stem cell-derived therapy for type 1 diabetes shows promising results

A stem cell-derived potential therapy VX-880 for treating Type 1 diabetes has resulted in a 91% decrease in daily insulin doses in first patient, according to a recent press release.

Vertex Pharmaceuticals Incorporated has shared results of Phase 1/2 of its clinical trial in which after only 90 days of its ongoing investigational study, the patient's insulin needs were reduced from 34 daily units down to 3 daily units.

For more details, check out the full story on the link below:

Novel Stem Cell-Derived Therapy For Type 1 Diabetes Shows Promising Results

Menstrual cycle length during menopause transition may predict risk of future atherosclerosis

Menstrual cycle length has been associated with different chronic conditions, including breast cancer, osteoporosis, and cardiovascular disease.

Changes in cycle length specifically during the menopause transition may also predict a woman's risk of developing atherosclerosis after menopause, finds a new study.

For more details, check out the full story on the link below:

Menstrual Cycle Length During Menopause Transition May Predict Risk Of Future Atherosclerosis

Case of Acute Intermittent Porphyria Presents As Posterior Reversible Encephalopathy Syndrome- A report

Acute intermittent porphyria (AIP) is an autosomal dominant inborn error caused due to inherited deficiency of porphobilinogen (PBG) deaminase leading to increased levels of aminolevulinic acid and PBG.

The most common presentation is an attack of severe abdominal pain without peritoneal signs, often accompanied by nausea, vomiting,tachycardia, hypertension, anxiety, and agitation. AIP is rarely associated with posterior reversible encephalopathy syndrome (PRES) and this association is important because drugs used in the management of seizures may worsen an attack of AIP.

For more details, check out the full story on the link below:

Rare Case Of Acute Intermittent Porphyria Presents As Posterior Reversible Encephalopathy Syndrome- A Report

Speakers

Roshni Dhar

Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be reached at editorial@medicaldialogues.in.